Second-line treatment of advanced urothelial cancer - safety of combinatory treatment with paclitaxel and RAD001 (everolimus) in a German phase II trial (AUO trial AB 35/09)
Dokumenttyp:
Meeting Abstract
Autor(en):
Niegisch, G; Retz, M; Hartmann, A; Thalgott, M; Gschwend, J; Vom Dorp, F; Stöckle, M; Ohlmann, C; Bogemann, M; Balabanov, S; Ohmann, C; Albers, P